United States · FDA National Drug Code directory
NALTREXONE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2062_84f6d9db-f1ef-4ddf-acdd-69e7742deefa
- Product NDC
- 71335-2062
- Form
- TABLET, FILM COATED
- Composition / generic term
- NALTREXONE HYDROCHLORIDE
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120229
- Source listing expiry
- 20271231
Source-listed ingredients
- NALTREXONE HYDROCHLORIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (71335-2062-1) · 71335-2062-1
- 90 TABLET, FILM COATED in 1 BOTTLE (71335-2062-2) · 71335-2062-2
- 60 TABLET, FILM COATED in 1 BOTTLE (71335-2062-3) · 71335-2062-3
- 45 TABLET, FILM COATED in 1 BOTTLE (71335-2062-4) · 71335-2062-4
- 120 TABLET, FILM COATED in 1 BOTTLE (71335-2062-5) · 71335-2062-5
- 15 TABLET, FILM COATED in 1 BOTTLE (71335-2062-6) · 71335-2062-6
- 100 TABLET, FILM COATED in 1 BOTTLE (71335-2062-7) · 71335-2062-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →